Polyganics Goes Shopping For Technology And Talent
This article was originally published in Clinica
Executive Summary
Get your product into market, grow sales, reach profitability. These are the key goals of any start-up but for biomaterials specialist Polyganics, being able to tick all those boxes was not enough. Instead, the Dutch SME is now setting off on the M&A trail to build critical mass, so as to unlock the significant value which it believes lies within its technology platform and R&D know-how.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.